The popular blood thinning drug Pradaxa has been prescribed to millions of patients with atrial fibrillation to prevent blood clots, stroke and pulmonary embolism. However, medication has been linked with dangerous health risks.
Authored by Chris Schroeder
Common Pradaxa side effects have been identified, including:
Researchers have also linked Pradaxa with these serious conditions:
Pradaxa is an anti-coagulant, often referred to as a blood thinner. While all blood thinner medications have a risk of internal bleeding, others like Coumadin (warfarin) can be effectively treated with “reversal agents.” With Pradaxa, there is no reversal agent to stop the bleeding – which can have life-threatening consequences.
The maker of Pradaxa faces liability because they did not warn patients of this risk.
The drug was FDA approved in 2010. By 2012, over 17,000 people reported adverse side effects where Pradaxa was the primary suspect, according to an FDA database. The most commonly reported Pradaxa side effects were internal bleeding, indigestion, and hemorrhage. Also, 6,249 hospitalizations and 1,847 patient deaths were determined to be due to Pradaxa.
If you or a loved one suffered internal bleeding after taking Pradaxa, it is important to learn about your legal rights by speaking with a lawyer. They can advise of the compensation available to your family and how long you have to take action. Contact us today for more information.
Early Pradaxa research was conducted in the RE-LY clinical trials, which were the basis for FDA approval. Some researchers now suggest that only certain results of the trials were made public, while safety risks were not disclosed.
Within weeks of the FDA’s approval of Pradaxa, further research by MedWatch showed the agency had received more reports of Pradaxa side effects compared to 98% of other drugs on the market. Complaints included internal bleeding in the brain, intestines and kidneys, as well as heart attacks.
Health experts continue to disagree over the safety of Pradaxa and whether it carries higher risks for internal bleeding. The FDA recently stated it is as safe as the traditional blood thinner warfarin. The Institute for Safe Medication Practices, however, has classified it as one of the most dangerous drugs on the market. They also warned that patients suffering internal bleeding Pradaxa side effects may be 5 times as likely to die than those with bleeding from Coumadin or warfarin.
The American College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin. Researchers from the University of Illinois at Chicago cautioned that the risk for Pradaxa bleeding may be higher than the FDA expected. The European Medicines Agency also issued a warning on internal bleeding risks.
Most recently, Danish researchers found that switching from other blood thinners to Pradaxa may lead to higher risks of internal bleeding.
In the United States, Boehringer Ingelheim faces thousands of lawsuits from patients affected by internal bleeding. A federal judge recently blocked attempts by the company to dismiss victims’ cases, giving those affected the ability to file lawsuits against the manufacturer. If you or a loved have suffered bleeding, it is important to speak with a lawyer.
Lawyers are helping victims file claims against the manufacturer. Due to the number of lawsuits expected, the cases have been consolidated to a special federal court in Illinois. A lawyer can let you know what compensation is available and how long you have to take action.
In seeking legal counsel, make sure your lawyer is experienced in this type of drug injury lawsuit and with fighting large drug companies . Due to the complexities of these cases, the DrugNews Resource Center only recommends law firms that have handled numerous Pradaxa lawsuits.
For more information on the side effects, warnings and legal action related to the drug Pradaxa, or to speak with a lawyer, contact us today. We are available 24 hours a day to provide help.
Last Modified: Monday, March 10, 2014